Proton magnetic resonance spectroscopy of patients with parkinsonism
- 1 August 2000
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 52 (6) , 589-595
- https://doi.org/10.1016/s0361-9230(00)00321-x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Unchanged basal ganglia N‐acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopyMovement Disorders, 1997
- Clinical and magnetic resonance image correlation in idiopathic cerebellar ataxiaJournal of the Neurological Sciences, 1995
- “Pure” striatonigral degeneration and Parkinson's disease: A comparative clinical studyMovement Disorders, 1995
- Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlationsMagnetic Resonance in Medicine, 1994
- Criteria for diagnosing Parkinson's diseaseAnnals of Neurology, 1992
- Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PETMovement Disorders, 1992
- Positron Emission Tomography Study in Progressive Supranuclear PalsyArchives of Neurology, 1990
- N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brainNeuroscience & Biobehavioral Reviews, 1989
- The `subcortical dementia' of progressive supranuclear palsyJournal of Neurology, Neurosurgery & Psychiatry, 1974